HEXAOM (ALHEX.PA) Fundamental Analysis & Valuation

EPA:ALHEX • FR0004159473

Current stock price

32.8 EUR
-0.2 (-0.61%)
Last:

This ALHEX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALHEX.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALHEX was profitable.
  • ALHEX had a negative operating cash flow in the past year.
  • ALHEX had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years ALHEX had a positive operating cash flow.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.46%, ALHEX is in line with its industry, outperforming 51.61% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 3.94%, ALHEX is in line with its industry, outperforming 51.61% of the companies in the same industry.
  • The Return On Invested Capital of ALHEX (3.70%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALHEX is in line with the industry average of 10.47%.
  • The last Return On Invested Capital (3.70%) for ALHEX is well below the 3 year average (8.77%), which needs to be investigated, but indicates that ALHEX had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROIC 3.7%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.46%, ALHEX is in line with its industry, outperforming 48.39% of the companies in the same industry.
  • ALHEX's Profit Margin has declined in the last couple of years.
  • ALHEX has a Operating Margin of 2.30%. This is comparable to the rest of the industry: ALHEX outperforms 41.94% of its industry peers.
  • ALHEX's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 21.14%, ALHEX is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
  • ALHEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

3

2. ALHEX.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALHEX is still creating some value.
  • Compared to 1 year ago, ALHEX has about the same amount of shares outstanding.
  • Compared to 1 year ago, ALHEX has an improved debt to assets ratio.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • ALHEX has an Altman-Z score of 2.12. This is not the best score and indicates that ALHEX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.12, ALHEX is in line with its industry, outperforming 58.06% of the companies in the same industry.
  • ALHEX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • ALHEX's Debt to Equity ratio of 0.40 is in line compared to the rest of the industry. ALHEX outperforms 54.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.12
ROIC/WACC0.53
WACC6.97%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • ALHEX has a Current Ratio of 1.31. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.31, ALHEX is in line with its industry, outperforming 41.94% of the companies in the same industry.
  • ALHEX has a Quick Ratio of 1.31. This is a bad value and indicates that ALHEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ALHEX (0.99) is better than 70.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.99
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. ALHEX.PA Growth Analysis

3.1 Past

  • The earnings per share for ALHEX have decreased strongly by -68.84% in the last year.
  • The earnings per share for ALHEX have been decreasing by -13.22% on average. This is quite bad
  • Looking at the last year, ALHEX shows a very negative growth in Revenue. The Revenue has decreased by -30.53% in the last year.
  • ALHEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.93% yearly.
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%

3.2 Future

  • ALHEX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.93% yearly.
  • ALHEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.02% yearly.
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y-0.74%
Revenue Next 3Y7.79%
Revenue Next 5Y3.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

4

4. ALHEX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALHEX is valuated quite expensively with a Price/Earnings ratio of 25.04.
  • ALHEX's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.21, ALHEX is valued at the same level.
  • The Price/Forward Earnings ratio is 8.17, which indicates a very decent valuation of ALHEX.
  • Based on the Price/Forward Earnings ratio, ALHEX is valued a bit cheaper than the industry average as 64.52% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ALHEX to the average of the S&P500 Index (23.13), we can say ALHEX is valued rather cheaply.
Industry RankSector Rank
PE 25.04
Fwd PE 8.17
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALHEX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.07
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALHEX does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as ALHEX's earnings are expected to grow with 37.93% in the coming years.
PEG (NY)10.27
PEG (5Y)N/A
EPS Next 2Y37.93%
EPS Next 3YN/A

2

5. ALHEX.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.60%, ALHEX has a reasonable but not impressive dividend return.
  • ALHEX's Dividend Yield is comparable with the industry average which is at 3.04.
  • ALHEX's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.6%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 2026 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y37.93%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

ALHEX.PA Fundamentals: All Metrics, Ratios and Statistics

HEXAOM

EPA:ALHEX (4/2/2026, 7:00:00 PM)

32.8

-0.2 (-0.61%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-10
Earnings (Next)N/A
Inst Owners15.78%
Inst Owner ChangeN/A
Ins Owners2.84%
Ins Owner ChangeN/A
Market Cap227.63M
Revenue(TTM)617.81M
Net Income(TTM)9.04M
Analysts86
Price Target46.41 (41.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.6%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 25.04
Fwd PE 8.17
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 2.25
EV/EBITDA 6.07
EPS(TTM)1.31
EY3.99%
EPS(NY)4.02
Fwd EY12.25%
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS89.02
BVpS33.03
TBVpS14.6
PEG (NY)10.27
PEG (5Y)N/A
Graham Number31.2
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROCE 4.7%
ROIC 3.7%
ROICexc 6.23%
ROICexgc 17.99%
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
FCFM N/A
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexgc growth 3Y-17.24%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 2.97
Cap/Depr 27.37%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.99
Altman-Z 2.12
F-Score4
WACC6.97%
ROIC/WACC0.53
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%
Revenue Next Year-11.32%
Revenue Next 2Y-0.74%
Revenue Next 3Y7.79%
Revenue Next 5Y3.02%
EBIT growth 1Y-50.48%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.13%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-114.31%
OCF growth 3Y-21.91%
OCF growth 5YN/A

HEXAOM / ALHEX.PA Fundamental Analysis FAQ

What is the fundamental rating for ALHEX stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALHEX.PA.


Can you provide the valuation status for HEXAOM?

ChartMill assigns a valuation rating of 4 / 10 to HEXAOM (ALHEX.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for HEXAOM?

HEXAOM (ALHEX.PA) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for ALHEX stock?

The Earnings per Share (EPS) of HEXAOM (ALHEX.PA) is expected to grow by 2.44% in the next year.


How sustainable is the dividend of HEXAOM (ALHEX.PA) stock?

The dividend rating of HEXAOM (ALHEX.PA) is 2 / 10 and the dividend payout ratio is 0%.